NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 35   

Articles published

NXTM 15.13 +0.01 (0.07%)
price chart
NxStage Medical Insider Robert S. Brown Sells 45370 Shares (NXTM)
NxStage Medical logo NxStage Medical (NASDAQ:NXTM) Insider Robert S. Brown sold 45,370 shares of the company's stock in a transaction dated Thursday, October 23rd. The shares were sold at an average price of $14.53, for a total value of $659,226.10.
Insider Selling: NxStage Medical President Unloads 3550 Shares of Stock (NXTM)
NxStage Medical logo NxStage Medical (NASDAQ:NXTM) President Joseph E. Turk, Jr. unloaded 3,550 shares of the company's stock in a transaction dated Thursday, October 23rd. The shares were sold at an average price of $14.55, for a total value of ...
Related articles »  
Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using ...
Investors considering a purchase of NxStage Medical Inc (Symbol: NXTM) stock, but cautious about paying the going market price of $13.65/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Related articles »  
NxStage Medical Inc.: NxStage� to Report Third Quarter 2014 Financial Results
LAWRENCE, Mass., Oct. 7, 2014 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the third quarter ended September 30, 2014, ...
Related articles »  
Insider Selling: NxStage Medical Insider Sells 45370 Shares of Stock (NXTM)
NxStage Medical logo NxStage Medical (NASDAQ:NXTM) Insider Robert S. Brown unloaded 45,370 shares of the company's stock on the open market in a transaction that occurred on Thursday, October 23rd. The stock was sold at an average price of $14.53 ...
Insider Selling: Joseph E. Turk, Jr. Sells 3550 Shares of NxStage Medical ...  sleekmoney
Related articles »  
NxStage Medical Stock Rating Reaffirmed by Canaccord Genuity (NXTM)
NxStage Medical, Inc. logo Canaccord Genuity reaffirmed their buy rating on shares of NxStage Medical (NASDAQ:NXTM) in a report issued on Tuesday.
Canaccord Genuity Reaffirms Buy Rating for NxStage Medical (NXTM)  WKRB News
NxStage Medical President Sells $47357 in Stock (NXTM)  Intercooler
Related articles »  
Grand Opening of NxStage Kidney Care Oak Brook IL Center
About NxStage Kidney Care NxStage Kidney Care Inc., a subsidiary of NxStage Medical, Inc. NXTM, +0.07% is innovating a dialysis care model that is intended to support and encourage patient-centered care and provide enhanced access to the ...
New NxStage Kidney Care center opens in Oak Brook, Illinois  News-Medical.net
Related articles »  
Stock Highlights : Advanced Micro Devices (NYSE:AMD), Aeterna Zentaris Inc ...
NxStage Medical (NASDAQ:NXTM) President Joseph E. Turk, Jr. unloaded 3,550 shares of the company's stock in a transaction dated Thursday, October 23rd.
Related articles »  
NxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center
LAWRENCE, Mass., Oct. 8, 2014 /PRNewswire/ -- NxStage� Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the grand opening of the company's South Orlando, Florida dialysis center.
Related articles »  
Big Movers: Montage Technology Group Limited (NASDAQ:MONT), The Boeing ...
NxStage Medical, Inc. (Nasdaq:NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the third quarter ended September 30, 2014, on Thursday, November 6, 2014, before the opening of the ...